forteo
eli lilly and company (nz) limited - teriparatide 250 µg/ml (rhpth(1-34)); - solution for injection - 250 mcg/ml - active: teriparatide 250 µg/ml (rhpth(1-34)) excipient: glacial acetic acid hydrochloric acid mannitol metacresol sodium acetate sodium hydroxide water for injection - forteo, in combination with calcium and vitamin d, is indicated for the treatment of osteoporosis in postmenopausal women and in men at high risk of fracture.
sular- nisoldipine tablet, film coated, extended release
covis pharma us, inc - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.
sular- nisoldipine tablet, film coated, extended release
shionogi inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.
sular- nisoldipine tablet, film coated, extended release
physicians total care, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 25.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.
nisoldipine 10mg modified-release tablets
special order - nisoldipine - modified-release tablet - 10mg
nisoldipine 20mg modified-release tablets
special order - nisoldipine - modified-release tablet - 20mg
nisoldipine 30mg modified-release tablets
special order - nisoldipine - modified-release tablet - 30mg
rifadin 600mg powder and solvent for solution for infusion vials
sanofi - rifampicin - powder and solvent for solution for infusion - 600mg
sporanox i.v. 250mg/25ml solution for infusion ampoules and diluent
janssen-cilag ltd - itraconazole - solution for infusion - 10mg/1ml
phenytoin sandoz
novartis new zealand ltd - phenytoin sodium 50 mg/ml - solution for injection - 50 mg/ml - active: phenytoin sodium 50 mg/ml excipient: ethanol propylene glycol sodium hydroxide water for injection